Design of T-cell receptor libraries with diverse binding properties to examine adoptive T-cell responses

A. S. Chervin, J. D. Stone, C. M. Soto, B. Engels, H. Schreiber, Edward J Roy, David M Kranz

Research output: Contribution to journalArticle

Abstract

Adoptive T-cell therapies have shown significant promise in the treatment of cancer and viral diseases. One approach, which introduces antigen-specific T-cell receptors (TCRs) into ex vivo activated T cells, is designed to overcome central tolerance mechanisms that prevent responses by endogenous T-cell repertoires. Studies have suggested that use of higher-affinity TCRs against class I major histocompatibility complex antigens could drive the activity of both CD4 + and CD8 + T cells, but the rules that govern the TCR binding optimal for in vivo activity are unknown. Here, we describe a high-throughput platform of 'reverse biochemistry' whereby a library of TCRs with a wide range of binding properties to the same antigen is introduced into T cells and adoptively transferred into mice with antigen-positive tumors. Extraction of RNA from tumor-infiltrating lymphocytes (TILs) or lymphoid organs allowed high-throughput sequencing to determine which TCRs were selected in vivo. The results showed that CD8 + T cells expressing the highest-affinity TCR variants were deleted in both the TIL population and in peripheral lymphoid tissues. In contrast, these same high-affinity TCR variants were preferentially expressed within CD4 + T cells in the tumor, suggesting they had a role in antigen-specific tumor control. The findings thus revealed that the affinity of the transduced TCRs controlled the survival and tumor infiltration of the transferred T cells. Accordingly, the TCR library strategy enables rapid assessment of TCR-binding properties that promote peripheral T-cell survival and tumor elimination.

Original languageEnglish (US)
Pages (from-to)634-644
Number of pages11
JournalGene therapy
Volume20
Issue number6
DOIs
StatePublished - Jun 1 2013

Fingerprint

T-Cell Antigen Receptor
T-Lymphocytes
Tumor-Infiltrating Lymphocytes
Neoplasm Antigens
Neoplasms
Central Tolerance
Histocompatibility Antigens Class I
Lymphoid Tissue
Virus Diseases
Cell- and Tissue-Based Therapy
Major Histocompatibility Complex
Biochemistry
Cell Survival
RNA
Antigens

Keywords

  • Adoptive T-cell therapy
  • Affinity engineering
  • T-cell display
  • TCR
  • Tumor targeting

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics

Cite this

Design of T-cell receptor libraries with diverse binding properties to examine adoptive T-cell responses. / Chervin, A. S.; Stone, J. D.; Soto, C. M.; Engels, B.; Schreiber, H.; Roy, Edward J; Kranz, David M.

In: Gene therapy, Vol. 20, No. 6, 01.06.2013, p. 634-644.

Research output: Contribution to journalArticle

Chervin, A. S. ; Stone, J. D. ; Soto, C. M. ; Engels, B. ; Schreiber, H. ; Roy, Edward J ; Kranz, David M. / Design of T-cell receptor libraries with diverse binding properties to examine adoptive T-cell responses. In: Gene therapy. 2013 ; Vol. 20, No. 6. pp. 634-644.
@article{160a66d5a8dd4002959062759651e491,
title = "Design of T-cell receptor libraries with diverse binding properties to examine adoptive T-cell responses",
abstract = "Adoptive T-cell therapies have shown significant promise in the treatment of cancer and viral diseases. One approach, which introduces antigen-specific T-cell receptors (TCRs) into ex vivo activated T cells, is designed to overcome central tolerance mechanisms that prevent responses by endogenous T-cell repertoires. Studies have suggested that use of higher-affinity TCRs against class I major histocompatibility complex antigens could drive the activity of both CD4 + and CD8 + T cells, but the rules that govern the TCR binding optimal for in vivo activity are unknown. Here, we describe a high-throughput platform of 'reverse biochemistry' whereby a library of TCRs with a wide range of binding properties to the same antigen is introduced into T cells and adoptively transferred into mice with antigen-positive tumors. Extraction of RNA from tumor-infiltrating lymphocytes (TILs) or lymphoid organs allowed high-throughput sequencing to determine which TCRs were selected in vivo. The results showed that CD8 + T cells expressing the highest-affinity TCR variants were deleted in both the TIL population and in peripheral lymphoid tissues. In contrast, these same high-affinity TCR variants were preferentially expressed within CD4 + T cells in the tumor, suggesting they had a role in antigen-specific tumor control. The findings thus revealed that the affinity of the transduced TCRs controlled the survival and tumor infiltration of the transferred T cells. Accordingly, the TCR library strategy enables rapid assessment of TCR-binding properties that promote peripheral T-cell survival and tumor elimination.",
keywords = "Adoptive T-cell therapy, Affinity engineering, T-cell display, TCR, Tumor targeting",
author = "Chervin, {A. S.} and Stone, {J. D.} and Soto, {C. M.} and B. Engels and H. Schreiber and Roy, {Edward J} and Kranz, {David M}",
year = "2013",
month = "6",
day = "1",
doi = "10.1038/gt.2012.80",
language = "English (US)",
volume = "20",
pages = "634--644",
journal = "Gene Therapy",
issn = "0969-7128",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Design of T-cell receptor libraries with diverse binding properties to examine adoptive T-cell responses

AU - Chervin, A. S.

AU - Stone, J. D.

AU - Soto, C. M.

AU - Engels, B.

AU - Schreiber, H.

AU - Roy, Edward J

AU - Kranz, David M

PY - 2013/6/1

Y1 - 2013/6/1

N2 - Adoptive T-cell therapies have shown significant promise in the treatment of cancer and viral diseases. One approach, which introduces antigen-specific T-cell receptors (TCRs) into ex vivo activated T cells, is designed to overcome central tolerance mechanisms that prevent responses by endogenous T-cell repertoires. Studies have suggested that use of higher-affinity TCRs against class I major histocompatibility complex antigens could drive the activity of both CD4 + and CD8 + T cells, but the rules that govern the TCR binding optimal for in vivo activity are unknown. Here, we describe a high-throughput platform of 'reverse biochemistry' whereby a library of TCRs with a wide range of binding properties to the same antigen is introduced into T cells and adoptively transferred into mice with antigen-positive tumors. Extraction of RNA from tumor-infiltrating lymphocytes (TILs) or lymphoid organs allowed high-throughput sequencing to determine which TCRs were selected in vivo. The results showed that CD8 + T cells expressing the highest-affinity TCR variants were deleted in both the TIL population and in peripheral lymphoid tissues. In contrast, these same high-affinity TCR variants were preferentially expressed within CD4 + T cells in the tumor, suggesting they had a role in antigen-specific tumor control. The findings thus revealed that the affinity of the transduced TCRs controlled the survival and tumor infiltration of the transferred T cells. Accordingly, the TCR library strategy enables rapid assessment of TCR-binding properties that promote peripheral T-cell survival and tumor elimination.

AB - Adoptive T-cell therapies have shown significant promise in the treatment of cancer and viral diseases. One approach, which introduces antigen-specific T-cell receptors (TCRs) into ex vivo activated T cells, is designed to overcome central tolerance mechanisms that prevent responses by endogenous T-cell repertoires. Studies have suggested that use of higher-affinity TCRs against class I major histocompatibility complex antigens could drive the activity of both CD4 + and CD8 + T cells, but the rules that govern the TCR binding optimal for in vivo activity are unknown. Here, we describe a high-throughput platform of 'reverse biochemistry' whereby a library of TCRs with a wide range of binding properties to the same antigen is introduced into T cells and adoptively transferred into mice with antigen-positive tumors. Extraction of RNA from tumor-infiltrating lymphocytes (TILs) or lymphoid organs allowed high-throughput sequencing to determine which TCRs were selected in vivo. The results showed that CD8 + T cells expressing the highest-affinity TCR variants were deleted in both the TIL population and in peripheral lymphoid tissues. In contrast, these same high-affinity TCR variants were preferentially expressed within CD4 + T cells in the tumor, suggesting they had a role in antigen-specific tumor control. The findings thus revealed that the affinity of the transduced TCRs controlled the survival and tumor infiltration of the transferred T cells. Accordingly, the TCR library strategy enables rapid assessment of TCR-binding properties that promote peripheral T-cell survival and tumor elimination.

KW - Adoptive T-cell therapy

KW - Affinity engineering

KW - T-cell display

KW - TCR

KW - Tumor targeting

UR - http://www.scopus.com/inward/record.url?scp=84882276058&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882276058&partnerID=8YFLogxK

U2 - 10.1038/gt.2012.80

DO - 10.1038/gt.2012.80

M3 - Article

C2 - 23052828

AN - SCOPUS:84882276058

VL - 20

SP - 634

EP - 644

JO - Gene Therapy

JF - Gene Therapy

SN - 0969-7128

IS - 6

ER -